OraSure Technologies | OSUR - Gross Profit On Sales


OraSure Technologies reported $11.34M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
AngioDynamics USD 44.78M 2.93M Sep/2025
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Bio Techne USD 222.15M 13.86M Jun/2026
Bio-Rad Laboratories USD 345.8M 36.4M Jun/2026
Bruker USD 416M 36.2M Jun/2026
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 348.78M 69.47M Jun/2026
Danaher USD 3.61B 20M Jun/2026
Dentsply International USD 493M 66M Jun/2026
Dexcom USD 750.3M 42.4M Mar/2026
Illumina USD 770M 49M Jun/2026
Integra LifeSciences USD 215.97M 2.77M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Mettler Toledo International USD 555.82M 119.62M Mar/2026
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD 223.9M 315.7M Jun/2026
Repligen USD 110.04M 1.75M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
STAAR Surgical USD 69.73M 868K Jun/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Trinity Biotech USD 6.47M 1.59M Sep/2025
Waters USD 490M 52M Jun/2026